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Abstract
Hyperlipidemia and hyperglycemia frequently occur in obese population. As
chronic, low-grade inflammation is closely associated with obesity, we investigated
if polyphenol-rich blackcurrant extract (BCE) can prevent inflammation and dietinduced metabolic disturbances in mice. Male C57BL/6J mice were given a modified
AIN-93M control diet containing high fat/high cholesterol (16% fat, 0.25%
cholesterol by weight) or the same diet supplemented with 0.1% BCE (wt/wt) for
12 weeks. No significant differences in total body weight or liver weight occurred
between the two groups. BCE-fed mice had fewer crown-like structures (CLS) with
concomitant decreases in mRNA abundance of F4/80, CD68, and inhibitor of nuclear
factor kB kinase e (IKKe) in the epididymal adipose tissue. F4/80 and IKKe mRNA
levels were positively and significantly correlated with CLS number. BCE-fed mice
demonstrated a significantly lower plasma total cholesterol (TC) and glucose levels
than controls, but no significant difference in plasma triglyceride (TG) levels. BCE
supplementation did not significantly alter mRNA levels of major regulators of

hepatic cholesterol metabolism, i.e., HMG-CoA reductase (HMGR) and low density
lipoprotein receptor (LDLR). However, protein expression levels of mature sterolregulatory element binding protein 2 as well as LDLR were significantly increased.
In the livers of mice fed BCE, there was a significant decrease in expression of
proprotein convertase subtilisin/kexin type 9 (PCSK9), which facilitates LDLR
protein degradation, as well as one of its transcriptional regulators, i.e., hepatocyte
nuclear factor 4 alpha. The skeletal muscle of BCE-fed mice showed a significant
increase in mRNA expression of genes involved in energy expenditure and
mitochondria biogenesis, including peroxisome proliferator activated receptor
alpha (PPARalpha), PPARdelta, uncoupling protein 2 (UCP-2), UCP-3, and
mitochondrial transcription factor A (TFAM). Upon stimulating splenocytes from
BCE-fed mice with lipopolysaccharides, tumor necrosis factor alpha and interleukin1beta mRNA levels were significantly lower than control mice (4). The results
suggest that BCE supplementation decreases obesity-induced inflammation in
adipose tissue and splenocytes, at least in part, by modulating energy metabolism in
skeletal muscle. Beneficial effects of BCE on plasma TC and glucose, liver steatosis
suggest that this berry may be consumed to prevent metabolic dysfunctions induced
by diets high in fat and cholesterol.

Introduction
Obesity is a widely-noted global health concern, and in the U.S. current rates
demonstrate as many as 42% of adults are projected to become obese by the year

2030 (19). It remains a leader in preventable causes of death, falling close behind
tobacco smoking and elevated blood pressure (13). Chronic low-grade inflammation
has been demonstrated to cause obesity-related metabolic diseases, such as insulin
resistance, hyperlipidemia, hyperglycemia, type 2 diabetes, cardiovascular disease
(CVD), and non-alcoholic fatty liver disease (NAFLD) (67). However, research has
uncovered that a subset of obese persons can be metabolically healthy, which
decreases the risk of secondary pathogenic obesity-associated diseases (83). This
indicates that obesity alone may not result in metabolic dysfunction, but rather
contributes to the progression of pathogenesis for secondary diseases.
Metabolic stress resulting from fat overload, and subsequent recruitment of
monocytes to adipose tissue is the cause of chronic local inflammation (27). This
occurs by inducing the production of pro-inflammatory mediators in lipid-laden
adipose tissue (3). Pharmaceuticals such as non-steroidal anti-inflammatory drugs
are common treatments for acute and chronic inflammatory conditions, however
they do come with adverse effects (32). In addition, the physiological characteristics
of obesity-induced chronic inflammation differ from other inflammatory disorders
such as arthritis and ulcerative colitis (37, 86). Therefore, identification of food
components with anti-inflammatory properties and minimal side effects are
critically needed. This will contribute to creating sufficient dietary strategies to
prevent obesity-associated metabolic disorders.
Epidemiological studies have indicated that diets containing high levels of
fruits and vegetables are inversely associated with the pathogenesis of obesity and
CVD (81). These beneficial effects are associated with the high polyphenol content of

fruits and vegetables (56). Of the various polyphenols found in fruits, anthocyanins
are the most abundant (28) and found in a wide array of berries such as blueberries,
cranberries, raspberries, blackberries, chokeberries, and acai berries (87). Berries
are of particular interest due to their purported health benefits, which are largely
correlated with their high polyphenol content (6, 14, 18, 66, 82, 88). These benefits
have been attributed to preventing cancer, diabetes, and other inflammatory
diseases (24, 75, 88). Though blueberry, cranberry, blackberry, and raspberry are
commonly consumed in the U.S., blackcurrant has recently increased in popularity.
Blackcurrant is rich in anthocyanins and vitamin C (74), and is known to hold a
higher antioxidant capacity compared to other commonly consumed berries (46, 51,
84).
Studies have demonstrated that blackcurrant exhibits anti-inflammatory,
antioxidant, and anti-microbial effects, which could provide potential health benefits
against hypertension, CVD, neurodegenerative disease, ocular diseases, and
hypercholesterolemia (20, 25, 30, 35, 40, 74, 78, 79). Consumption of blackcurrant
has also been shown to improve insulin sensitivity and inhibit inflammation (45).
However, the mechanisms of action for the effects of blackcurrant on obesityassociated inflammation have never been investigated. The goal of this study was to
determine the possible roles and mechanisms of polyphenol-rich blackcurrant
extract (BCE) in preventing obesity-associated metabolic abnormalities in mice fed a
diet high in fat and cholesterol (4).

Materials and Methods
Animal care and diet
Male C57BL/6J mice (Jackson Laboratory, Bar Harbor, ME) at 15 weeks of
age were randomly assigned into a control or BCE group. The control group of 11
mice received a modified AIN-93M containing high fat/high cholesterol diet (HF/HC;
16% fat, 0.25% cholesterol by weight; 55.7%, 125.5%, and 31.8% energy from
carbohydrate, protein, and fat, respectively; 4529 kcal/g). The BCE group was fed a
HF/HC diet supplemented with 0.1% of BCE by weight. Artemis International, Inc
graciously supplied the standardized BCE powder containing 25% anthocyanins and
40% polyphenols. Based on body surface normalization to a 70 kg individual (62),
0.1% BCE containing 25% anthocyanins is equivalent to daily consumption of ~540
mg BCE and 135 mg anthocyanins in humans. As the average daily intake of
anthocyanins per person has been estimated to be ~200 mg in the U.S. (45), we
believe the dietary level of berry extracts is attainable in humans (4). While
developing HF-induced obesity, mice were given BCE to determine its preventative
effects on obesity and its associated dysfunctions. Housing for mice was maintained
in a controlled environment with 12h light/dark cycles and ad libitum feeding
during the course of the study. Weekly body weight and food consumption were
recorded along with monthly blood draws from the lateral tail vein. Post 12 weeks
on the experimental diets, mice were fasted for 8 h and anaesthetized by injecting
ketamine/xylazine (100/10 mpk) (Henry Schein Animal Health, Dublin, OH) (4).
Cardiac puncture was used to collect ~1mL blood samples into a BD vacutainer
containing EDTA, and mice were sacrificed by exsanguination followed by cervical

dislocation. Epididymal and retroperitoneal fat pads were harvested, weighed, and
snap frozen in liquid nitrogen for later use in gene analysis, or were fixed in 10%
formalin for histological analysis. Gastrocnemius muscle samples were also
collected, snap frozen in liquid nitrogen, and stored at -80oC for gene analysis (4).
Blood was centrifuged at 1,500xg for 10 min at 4oC. Livers were weighed, and
subsamples were snap frozen in liquid nitrogen and stored at 80oC until use or fixed
in 10% formalin (4). The Institutional Animal Care and Use Committee of the
University of Connecticut approved all animal procedures.

Gene expression analysis of liver and muscle by quantitative realtime PCR (qRT-PCR)
Total RNA extraction was performed on liver samples, epididymal fats, and
muscle tissue using TRIzol reagent (Invitrogen, Grand Island, NY). The expression of
genes involved in fat, cholesterol, and glucose metabolism was measured using qRTPCR analysis. This was accomplished using the SYBR Green procedure and CFX96
realtime PCR detection system (BioRad, Hercules, CA) (40, 41, 42, 43, 59, 85, 86).
Primer sequences were designed according to GenBank database using the Beacon
Designer software (Premier Biosoft, Palo Alto, CA). Ribosomal protein large P0
(RPLP0) and Beta-actin represent the internal controls, and were used in calculating
2-∆∆Ct. These values were used to ascertain the validity of the chosen internal control
for the analysis. Using each internal control, the data analyzed demonstrated a
similar trend of changes in gene expression and the data reported in this study used
RPLP0 as an internal control.

Western blot analysis
Western blot analysis was performed with liver lysates (61). Antibodies used
were: low-density lipoprotein receptor (LDLR; Abcam, Cambridge, MA), HMG-CoA
reductase (HMGR; Santa Cruz Biotechnology, Dallas, TX), mature sterol-regulatory
element binding protein 2 (mSREBP-2; Abcam) and beta-actin (Sigma, St. Louis, MO)
(4). Blots were developed using horseradish peroxidase (Thermo Fisher Scientific,
Rockford, IL) and densitometry analysis was performed using Chemidoc XRS+ (BioRad) and Image Lab software (Bio-Rad). Beta-actin was used as a loading control
(4).

Statistical Analysis
Student’s conducted t-tests and results were used with the GraphPad Instat 6
(GraphPad Software, La Jolla, CA) to compare mean differences between groups. All
data are expressed as means ± SEM, and an alpha-level of P<0.05 was considered
statistically significant (4).

Results
Reduced expression of lipogenic genes in hepatic tissue by BCE supplementation
Measuring the hepatic expression of LDLR and HMGR, and mSREBP-2, a
transcriptional regulator of LDLR and HMGR, provided mechanistic insight into the
total cholesterol-lowering effects of BCE. The abundance of mRNA for LDLR and
HMGR did not indicate a statistically significant difference between control and BCE
groups (Figure 1A). However, Western blot analysis did indicate significantly higher

protein levels of mSREBP-2 and LDLR in mice fed BCE-diets than controls, but
showed no difference in HMGR protein levels (Figure 1B and C). mRNA expression
of fatty acid oxidation genes, carnitine palmitoyltransferase 1 (CPT-1), CPT-1,
and acylCoA oxidase 1 (ACOX-1), were not significantly altered by supplementation
with BCE (Figure 2). Hepatic expression of gluconeogenic genes, as in
phosphoenolpyruvate carboxykinase (PEPCK) and glucose-6-phosphate (G6P),
showed no significant difference for both groups.

Alterations in the expression of metabolic genes in the muscle by BCE supplementation
Although the percentage of epididymal fat weight was significantly reduced
in the BCE-fed mice, there were no significant differences in the expression of genes
involved in lipid synthesis and fatty acid oxidation, such as SREBP-1c, PPARγ, fatty
acid synthase (FAS), stearoyl CoA desaturase 1 (SCD-1), CPT-1α and 1β, in the
epididymal fat (data not shown).
To investigate the potential effect of BCE supplementation on energy
metabolism in muscle, which would contribute to potential alterations in total body
weight, we measured expression of genes involved in fatty acid beta oxidation and
mitochondrial uncoupling/biogenesis. PPAR, PPAR, UCP-2, UCP-3, and TFAM
expression demonstrated significant increases in the muscle of BCE-fed mice
compared to the control group (Figure 3, 4, and 5). In addition, BCE
supplementation showed a trend toward increased in expression of ACOX-1 and
peroxisome proliferator-activated receptor  coactivator 1 (PGC-1).

Discussion
Obesity significantly increases the risk of CVD, NAFLD, diabetes mellitus,
hypertension, arthritis, asthma, and cancer, which remain major health problems in
the U.S. (71). Chronic, low-grade inflammation is a common factor associated with
the pathogenesis of obesity-related metabolic diseases (71). Identifying dietary
products that lower blood lipids and glucose would contribute to lowering the
disease risk. Many natural food products having anti-inflammatory properties have
been identified, though novel discoveries would contribute to the list of potentially
therapeutic dietary components (3). Blackcurrant cultivation doesn’t have a
substantial history in the U.S., however its potential health benefits have granted it a
significant amount of attention. Blackcurrant has been demonstrated to have a
myriad of therapeutic properties, acting as an antioxidant, anti-inflammatory, and
anti-microbial agent [25]. However, the role of blackcurrant in modulating obesityinduced inflammatory conditions has yet to be investigated (3). This study shows
that BCE supplementation lowered plasma TC and decreased fat accumulation in the
liver and plasma glucose, without altering the expression of genes involved in
lipogenesis, fatty acid oxidation, or gluconeogenesis. We presume that the
prevention of hepatic steatosis and hyperglycemia by BCE supplementation is
secondary to its effects on extra-hepatic tissues, such as skeletal muscle.
Skeletal muscle is a metabolically active tissue that contributes largely to
energy expenditure in the body. Due to the absence of change in regard to lipogenic
and fatty acid oxidative gene expression in adipose tissue by BCE supplementation,
despite less macrophage infiltration, we investigated the effect of BCE on lipid

metabolism and mitochondrial biogenesis in skeletal muscle. In mice fed a BCE-diet
compared to controls, fatty acid beta-oxidation genes, i.e. CPT-1, CPT-1, and
ACOX-1, showed no significant difference coupled with an increasing trend for
ACOX-1 (P = 0.08). Although, an observed significant induction of PPAR and PPAR
by BCE supplementation in muscle with an associated increase in UCP-2 and UCP-3
expression was noted. The PPAR genes have been demonstrated to act as
transcriptional regulators for UCP-2 and UCP-3 expression in skeletal muscle tissue
[80]. UCP1 functions mainly in brown adipose tissue, while UCP2 and UCP3 are
expressed in other tissues including skeletal muscle [57]. UCP-2 and UCP-3 act by
uncoupling respiration from ATP synthesis in the mitochondria, which facilitates the
dissipation of energy as heat [34] and prevents buildup of reactive oxygen species
[44, 55]. UCP-2 and UCP-3 have also been shown to play important roles in glucose
and lipid metabolism [15, 33]. As an example, UCP-3 overexpression in skeletal
muscle of mice was shown to protect against obesity by lowering fasting plasma
glucose and insulin [10]. Concurrent with this observation, we also saw a ~35%
reduction in fasting plasma glucose for the BCE group (data not shown). In addition,
we also saw a significant increase in TFAM expression coupled with an increasing
trend in PGC-1, a large component in mitochondrial biogenesis and uncoupling
[17], in the skeletal muscle of BCE mice. Further investigation is necessary to
address if BCE enhances mitochondria biogenesis and energy expenditure in
skeletal muscle; however, our observations strongly suggest that BCE may exercise
its anti-inflammatory properties in adipose tissue by modulating energy metabolism
in skeletal muscle (3).

Achieving the preventative and therapeutic goal to lower circulating
cholesterol is accomplished by the induction of LDLR expression and activity in the
liver. Prescribed cholesterol-lowering drugs, such as statins, inhibit HMGR activity
which in turn increases LDLR expression [26]. Inducing LDLR expression mainly
depends on SREBP-2, a widely recognized transcriptional regulator of LDLR, which
also acts by upregulating HMGR expression [69]. High levels of cholesterol in the cell
cause insulin-induced genes (INSIG) to bind to SREBP-2 in complex with SREBP
cleavage-activating protein (SCAP) in the endoplasmic reticulum. This prevents the
translocation of the SREBP-2/SCAP complex to the Golgi [31]. Lowered levels of
cellular cholesterol cause the SREBP-2/SCAP complex to be released from INSIG and
transported to the Golgi, where it undergoes two step proteolytic cleavage, releasing
the N-terminal transcriptional activation domain, mSREBP-2, which in turn induces
LDLR and HMGR transcription. This study demonstrates that despite a substantial
increase in mSREBP-2 protein levels in the livers of BCE-fed mice, LDLR and HMGR
mRNA levels were not significantly altered. LDLR protein levels in the liver,
however, did increase by ~80% for the BCE group compared to the control group.
The result indicates that an increase LDLR protein is likely due to effects of BCE at a
post-transcriptional level.
Mice fed BCE, when compared to controls, showed attenuated liver steatosis
by histological analysis. We measured the expression of genes involved in
lipogenesis and fatty acid oxidation to investigate the mechanisms of action. BCE
supplementation was shown to significantly lower FAS mRNA in the liver, however
its protein levels revealed no difference between groups (data not shown). In

addition, a trend toward a decrease rather than increase for expression of genes
related to mitochondrial fatty acid oxidation, as in CPT-1α and 1β, was
demonstrated in the livers of BCE-fed mice. BCE supplementation did not alter
mRNA expression of ACOX-1, which is an important enzyme for peroxisomal fatty
acid oxidation. This indicates that the mechanism of action for BCE in inhibiting the
development of liver steatosis is not likely attributed to lipogenesis or fatty acid
oxidation (3). We are interested in the findings of our recent report indicating that
genes related to energy expenditure and mitochondrial biogenesis in the skeletal
muscle of BCE fed mice were significantly increased, including PPARα, PPARδ, UCP2, UCP-3, and TFAM [3]. No significant changes were detected in expression of genes
for lipid metabolism in the adipose tissue. These findings support the notion a
decrease in liver steatosis may prove secondary to the effects of BCE on energy
metabolism in the skeletal muscle. BCE supplementation also significantly
decreased plasma fasting glucose levels by ~35%, but did not significantly alter
hepatic expression of gluconeogenic genes, i.e., in G6P and PEPCK. UCP-2 and UCP-3
are known to play crucial roles in glucose and lipid metabolism [15, 33], and
overexpression of UCP-3 in skeletal muscle shows lowered fasting plasma glucose
and insulin [10]. Therefore, we propose the beneficial effects of BCE
supplementation in preventing liver steatosis and hyperglycemia are likely due to
enhanced energy utilization in the skeletal muscle. Further investigation should be
warranted to test this possibility.

Conclusion
This study is among the first to investigate the potential health benefits of
BCE in preventing obesity-induced inflammation and hyperglycemia. Although
further investigation is needed for understanding the exact mechanisms of action
for the beneficial effects of BCE, our study strongly suggests that BCE consumption
may prevent an array of metabolic dysfunctions related to high fat and high
cholesterol diet.
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Figure Legend
Figure 1. Expression of mRNA and protein levels of lipogenic genes in the livers of
male C57BL/6J mice fed a HF/HC control or 0.1% (w/w) BCE supplemented diet for
12 weeks. A. mRNA expression. B. Western blot image. C. Protein levels
(quantification). Values are means + SEM; n= 11 for control and 13 for BCE
Figure 2. Expression levels for genes involved in fatty acid beta-oxidation between
control and BCE mice; taken from skeletal muscle tissue.
Figure 3. Gene expression changes in lipid metabolism between control and BCE
groups.
Figure 4. Mitochondrial biogenesis gene expression trends in skeletal muscle.
Figure 5. Changes in expression of genes involved in mitochondrial uncoupling for
control and BCE groups.
Figure 2-5. Metabolic gene expression in skeletal muscle tissue taken from the
gastrocnemius of male C57BL/6J mice fed a HF/HC control or 0.1% (wt/wt) BCE
supplemented diet for 12 weeks. Data are expressed as relative expression to
control. Values are means + SEM; *, P<0.05; n= 11 for control and 13 for BCE
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